13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-17, with 58 holding rows worth $4,746,592,000.
- Accession
- 0001425738-15-000020
- Filer
- CIK 1425738
- Filed
- 2015-11-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 58 entries on the cover page, a total value of $4,746,592,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,746,592,000 with VALUE read as thousands by filing date, 13F file number 028-12776. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,137,559 | $1,022,386,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,142,864 | $626,030,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 1,390,173 | $469,684,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 1,462,699 | $423,974,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 769,641 | $392,004,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 1,028,132 | $298,843,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 514,107 | $258,490,000 | thousands by filing date | |
| RITEAID CORP | 767754104 | COM | 8,071,405 | $223,748,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 8,332,930 | $116,578,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 957,634 | $88,064,000 | thousands by filing date | |
| WELLCARE HEALTH PLANS INC | 94946T106 | COM | 514,273 | $81,627,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 17,750,510 | $80,942,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 1,752,642 | $74,487,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 613,598 | $67,698,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,322,592 | $52,957,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 1,562,587 | $51,010,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,067,978 | $40,797,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 747,460 | $40,535,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 368,775 | $38,839,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 1,049,782 | $33,005,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 1,385,641 | $22,170,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 1,954,019 | $20,595,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 532,818 | $18,963,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 724,348 | $17,775,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 947,966 | $17,604,000 | thousands by filing date | |
| MODEL N INC | 607525102 | COM | 1,443,278 | $14,447,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 688,845 | $12,441,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 262,892 | $11,084,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,074,836 | $11,059,000 | thousands by filing date | |
| Lowes Companies Inc | 42222G108 | LOW | 179,229 | $10,793,000 | thousands by filing date | |
| TRINET GROUP INC COM | 896288107 | Stock | 639,186 | $10,738,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 3,614,990 | $9,905,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 660,816 | $9,628,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 367,485 | $7,842,000 | thousands by filing date | |
| TRIVASCULAR TECHNOLOGIES INC | 89685A102 | COM | 1,463,983 | $7,320,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 1,603,427 | $7,280,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 514,300 | $7,236,000 | thousands by filing date | |
| AVALANCHE BIOT | 05337G107 | Common Stock | 748,420 | $6,167,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 277,000 | $6,102,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 2,613,316 | $5,096,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 590,100 | $4,986,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 660,129 | $4,766,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 4,000,000 | $3,942,000 | thousands by filing date | principal |
| CASTLIGHT HEALTH INC CL B | 14862Q100 | Stock | 734,397 | $3,084,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 500,615 | $3,029,000 | thousands by filing date | |
| PRESS GANEY HOL | 74113L102 | Common Stock | 84,966 | $2,514,000 | thousands by filing date | |
| SESEN BIO, INC. | 286221106 | COM | 848,351 | $2,045,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 190,789 | $1,988,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 25,000 | $1,160,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 91,644 | $628,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 9,250 | $576,000 | thousands by filing date | |
| MARKET VECTORS PHARM ETF T | 57060U217 | ETF | 6,500 | $409,000 | thousands by filing date | |
| Sierra Oncology, Inc. | 74346L101 | common | 18,391 | $377,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 16,056 | $311,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,769 | $235,000 | thousands by filing date | |
| CERNER CORP | 156782104 | COM | 3,563 | $214,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 24,583 | $199,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 11,800 | $186,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001425738-15-000020 | this filing | 2015-11-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001425738-15-000021 | base | 2015-11-17 | acceptance time not in the bulk data set |